References
- Department of Health, Ministry of Public Health, Thailand . The reproductive health survey. [online] 2009. [cited 2015 Jul 19]. Available from: http://rh.anamai.moph.go.th/all_file/index/RH.pdf
- Stubblefield PG, Roncari DM. Family planning. In: Berek JS, editor. Berek and Novak’s Gynecology, 15th ed. Philadelphia: Lippincott Williams and Wilkins, Wolters Kluwer Health; 2012. p. 211-69.
- Emans SJ, Grace E, Woods ER, Smith DE, Klein K, Merola J. Adolescents’ compliance with the use of oral contraceptives. JAMA. 1987; 257:3377-81.10.1001/jama.1987.03390240083028
- Panyawaranan P, Santibenchakul S, Jaisamrarn U. Compliance of different contraceptive methods in Thai women. Thai J Obstet Gynecol. 2015; 23:130-8.
- Dieben TO, Roumen FJ, Apter D. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol. 2002; 100: 585-93.12220783
- NuvaRing (For U.S. Health Care Professionals). [online] 2015. [cited 2015 Jul 27]. Available from: http://www.merck.com/product/usa/pi_circulars/n/nuvaring/nuvaring_pi.pdf
- Killick S. Complete and robust ovulation inhibition with NuvaRing. Eur J Contracept Reprod Health Care. 2002;7 (Suppl 2):13-8; discussion 37-9.12659397
- Roumen FJ, Apter D, Mulders TM, Dieben TO. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol. Hum Reprod. 2001; 16:469-75.10.1093/humrep/16.3.46911228213
- Roumen F. Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing. Eur J Contracept Reprod Health Care. 2002; 7 (Suppl 2):19-24; discussion 37-9.12659398
- Cagnacci A, Ferrari S, Tirelli A, Zanin R, Volpe A. Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study. Contraception. 2009; 80:34-9.10.1016/j.contraception.2009.01.01219501213
- Nguyen BT, Jensen JT. Evaluating the efficacy and safety of a progestin- and estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring. Expert Opin Drug Saf. 2014; 13:1423-30.10.1517/14740338.2014.94884225106828
- Pandit SN, Chauhan AR, Anagani M, Reddy S, Birla A, Ray SK. Multicenter study of contraceptive vaginal ring (NuvaRing®) in normal daily practice in Indian women. J Obstet Gynaecol India. 2014; 64: 409-16.10.1007/s13224-014-0559-725489144
- Department of Reproductive Health WHO. Medical eligibility criteria for contraceptive use. [online] 2009. [cited 2015 Apr 16]. Available from: http://www.who.int/reproductivehealth/publications/family_planning/Ex-Summ-MEC-5/en
- Bruni V, Pontello V, Luisi S, Petraglia F. An open-label, multicentre trial to evaluate the vaginal bleeding pattern of the combined contraceptive vaginal ring NuvaRing. Eur J Obstet Gynecol Reprod Biol. 2008; 139:65-71.1835858610.1016/j.ejogrb.2008.02.001
- Bjarnadottir RI, Tuppurainen M, Killick SR. Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ ethinyl estradiol. Am J Obstet Gynecol. 2002; 186: 389-95.10.1067/mob.2002.12110311904596
- Timmer CJ, Mulders TM. Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring. Clin Pharmacokinet. 2000; 39:233-42.10.2165/00003088-200039030-0000511020137
- Oddsson K, Leifels-Fischer B, de Melo NR, Wiel-Masson D, Benedetto C, Verhoeven CH, et al. Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial. Contraception. 2005; 71:176-82.10.1016/j.contraception.2004.09.00115722066
- Ahrendt HJ, Nisand I, Bastianelli C, Gomez MA, Gemzell-Danielsson K, Urdl W, et al. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone. Contraception. 2006; 74: 451-7.10.1016/j.contraception.2006.07.00417157101
- Sarkar NN. The combined contraceptive vaginal device (NuvaRing): a comprehensive review. Eur J Contracept Reprod Health Care. 2005; 10:73-8.10.1080/1362518050013168316147810